T cell responses during human immunodeficiency virus (hiv)-1 infection

Claire A. Chougnet, Barbara Shacklett

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The defining features of the acquired immunodeficiency are the-persistent and profound selective decrease in the function as well as number of T lymphocytes of the helper/inducer subset and a possible activation of the suppressor/cytotoxic subset, as described in 1982 (Mildvan, D., U. Mathur, et al. (1982). Opportunistic infections and immune deficiency in homosexual men. Ann Intern Med 96(6 Pt 1): 700-4). Nowadays, although depletion of CD4+ T-cells remains a hallmark of Human Immunodeficiency Virus (HIV) infection, the multifactorial nature of the disease provoked by infection by HIV-1 or Simian Immunodeficiency Virus (SIV) in non-natural hosts is generally acknowledged, in that no unique immune alteration has been identified that can fully explain the plethora of dysregulation associated with the development of pathogenic HIV and SIV infection. This review will focus on what we know (or do not know) about T cell responses during HIV infection. This choice reflects the main expertise of the authors, and the major theme of this book. However, other aspects of adaptive and innate immunity should not be overlooked. Notably, HIV-specific antibodies, including neutralizing antibodies, are an important defense of the adaptive immune system, although HIV appears to quickly evade the effect of these antibodies. Recent studies have also highlighted the role of innate immunity in protection against HIV/SIV. In addition, several cellular antiretroviral restriction factors, either constitutively expressed or induced by interferons, have been identified, which provide considerable-resistance to retroviral infection. For more on these topics, we refer readers to recent reviews summarizing these crucial aspects of the virus/host interaction (Kuritzkes, D. R. and B. D. Walker (2007). HIV-1 Pathogenesis, Clinical Manifestations and Treatment. Fields Virology. D. Knipe and P. M. Howley. Philadelphia, PA, Lippincott Williams & Wilkins. 2: 2187-2214; Levy, J. A. (2007). HIV and the Pathogenesis of AIDS. Washington, D.C., ASM Press; Zwick, M. B. and D. R. Burton (2007). HIV-1 neutralization: mechanisms and relevance to vaccine design. Curr HIV Res 5(6): 608-24; Alter, G. and M. Altfeld (2009). NK cells in HIV-1 infection: evidence for their role in the control of HIV-1-infection. J Intern Med 265(1): 29-42; Neil, S. and P. Bieniasz (2009). Human immunodeficiency virus, restriction factors, and interferon. J Interferon Cytokine Res 29(9): 569-80; Stamatatos, L., L. Morris, et al. (2009). Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine? Nat Med 15(8): 866-70; Strebel, K., J. Luban, et al. (2009). Human cellular-restriction factors that target HIV-1 replication. BMC Med 7: 48; Altfeld, M., L. Fadda, et al. (2011). DCs and NK cells: critical effectors in the immune response to HIV-1. Nat Rev Immunol 11(3): 176-86).

Original languageEnglish (US)
Title of host publicationControl of Innate and Adaptive Immune Responses during Infectious Diseases
PublisherSpringer New York
Pages141-169
Number of pages29
Volume9781461404842
ISBN (Electronic)9781461404842
ISBN (Print)1461404835, 9781461404835
DOIs
StatePublished - Oct 1 2012

Fingerprint

Virus Diseases
HIV-1
HIV
T-Lymphocytes
Simian Immunodeficiency Virus
Interferons
Neutralizing Antibodies
Innate Immunity
Natural Killer Cells
Vaccines
Virology
Antibodies
Opportunistic Infections
Adaptive Immunity
Virus Replication
Helper-Inducer T-Lymphocytes
Infection
Immune System
Acquired Immunodeficiency Syndrome
Cytokines

ASJC Scopus subject areas

  • Medicine(all)
  • Immunology and Microbiology(all)

Cite this

Chougnet, C. A., & Shacklett, B. (2012). T cell responses during human immunodeficiency virus (hiv)-1 infection. In Control of Innate and Adaptive Immune Responses during Infectious Diseases (Vol. 9781461404842, pp. 141-169). Springer New York. https://doi.org/10.1007/978-1-4614-0484-2_8

T cell responses during human immunodeficiency virus (hiv)-1 infection. / Chougnet, Claire A.; Shacklett, Barbara.

Control of Innate and Adaptive Immune Responses during Infectious Diseases. Vol. 9781461404842 Springer New York, 2012. p. 141-169.

Research output: Chapter in Book/Report/Conference proceedingChapter

Chougnet, CA & Shacklett, B 2012, T cell responses during human immunodeficiency virus (hiv)-1 infection. in Control of Innate and Adaptive Immune Responses during Infectious Diseases. vol. 9781461404842, Springer New York, pp. 141-169. https://doi.org/10.1007/978-1-4614-0484-2_8
Chougnet CA, Shacklett B. T cell responses during human immunodeficiency virus (hiv)-1 infection. In Control of Innate and Adaptive Immune Responses during Infectious Diseases. Vol. 9781461404842. Springer New York. 2012. p. 141-169 https://doi.org/10.1007/978-1-4614-0484-2_8
Chougnet, Claire A. ; Shacklett, Barbara. / T cell responses during human immunodeficiency virus (hiv)-1 infection. Control of Innate and Adaptive Immune Responses during Infectious Diseases. Vol. 9781461404842 Springer New York, 2012. pp. 141-169
@inbook{5def5e2da5ec4e2b8f187fbe94074550,
title = "T cell responses during human immunodeficiency virus (hiv)-1 infection",
abstract = "The defining features of the acquired immunodeficiency are the-persistent and profound selective decrease in the function as well as number of T lymphocytes of the helper/inducer subset and a possible activation of the suppressor/cytotoxic subset, as described in 1982 (Mildvan, D., U. Mathur, et al. (1982). Opportunistic infections and immune deficiency in homosexual men. Ann Intern Med 96(6 Pt 1): 700-4). Nowadays, although depletion of CD4+ T-cells remains a hallmark of Human Immunodeficiency Virus (HIV) infection, the multifactorial nature of the disease provoked by infection by HIV-1 or Simian Immunodeficiency Virus (SIV) in non-natural hosts is generally acknowledged, in that no unique immune alteration has been identified that can fully explain the plethora of dysregulation associated with the development of pathogenic HIV and SIV infection. This review will focus on what we know (or do not know) about T cell responses during HIV infection. This choice reflects the main expertise of the authors, and the major theme of this book. However, other aspects of adaptive and innate immunity should not be overlooked. Notably, HIV-specific antibodies, including neutralizing antibodies, are an important defense of the adaptive immune system, although HIV appears to quickly evade the effect of these antibodies. Recent studies have also highlighted the role of innate immunity in protection against HIV/SIV. In addition, several cellular antiretroviral restriction factors, either constitutively expressed or induced by interferons, have been identified, which provide considerable-resistance to retroviral infection. For more on these topics, we refer readers to recent reviews summarizing these crucial aspects of the virus/host interaction (Kuritzkes, D. R. and B. D. Walker (2007). HIV-1 Pathogenesis, Clinical Manifestations and Treatment. Fields Virology. D. Knipe and P. M. Howley. Philadelphia, PA, Lippincott Williams & Wilkins. 2: 2187-2214; Levy, J. A. (2007). HIV and the Pathogenesis of AIDS. Washington, D.C., ASM Press; Zwick, M. B. and D. R. Burton (2007). HIV-1 neutralization: mechanisms and relevance to vaccine design. Curr HIV Res 5(6): 608-24; Alter, G. and M. Altfeld (2009). NK cells in HIV-1 infection: evidence for their role in the control of HIV-1-infection. J Intern Med 265(1): 29-42; Neil, S. and P. Bieniasz (2009). Human immunodeficiency virus, restriction factors, and interferon. J Interferon Cytokine Res 29(9): 569-80; Stamatatos, L., L. Morris, et al. (2009). Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine? Nat Med 15(8): 866-70; Strebel, K., J. Luban, et al. (2009). Human cellular-restriction factors that target HIV-1 replication. BMC Med 7: 48; Altfeld, M., L. Fadda, et al. (2011). DCs and NK cells: critical effectors in the immune response to HIV-1. Nat Rev Immunol 11(3): 176-86).",
author = "Chougnet, {Claire A.} and Barbara Shacklett",
year = "2012",
month = "10",
day = "1",
doi = "10.1007/978-1-4614-0484-2_8",
language = "English (US)",
isbn = "1461404835",
volume = "9781461404842",
pages = "141--169",
booktitle = "Control of Innate and Adaptive Immune Responses during Infectious Diseases",
publisher = "Springer New York",

}

TY - CHAP

T1 - T cell responses during human immunodeficiency virus (hiv)-1 infection

AU - Chougnet, Claire A.

AU - Shacklett, Barbara

PY - 2012/10/1

Y1 - 2012/10/1

N2 - The defining features of the acquired immunodeficiency are the-persistent and profound selective decrease in the function as well as number of T lymphocytes of the helper/inducer subset and a possible activation of the suppressor/cytotoxic subset, as described in 1982 (Mildvan, D., U. Mathur, et al. (1982). Opportunistic infections and immune deficiency in homosexual men. Ann Intern Med 96(6 Pt 1): 700-4). Nowadays, although depletion of CD4+ T-cells remains a hallmark of Human Immunodeficiency Virus (HIV) infection, the multifactorial nature of the disease provoked by infection by HIV-1 or Simian Immunodeficiency Virus (SIV) in non-natural hosts is generally acknowledged, in that no unique immune alteration has been identified that can fully explain the plethora of dysregulation associated with the development of pathogenic HIV and SIV infection. This review will focus on what we know (or do not know) about T cell responses during HIV infection. This choice reflects the main expertise of the authors, and the major theme of this book. However, other aspects of adaptive and innate immunity should not be overlooked. Notably, HIV-specific antibodies, including neutralizing antibodies, are an important defense of the adaptive immune system, although HIV appears to quickly evade the effect of these antibodies. Recent studies have also highlighted the role of innate immunity in protection against HIV/SIV. In addition, several cellular antiretroviral restriction factors, either constitutively expressed or induced by interferons, have been identified, which provide considerable-resistance to retroviral infection. For more on these topics, we refer readers to recent reviews summarizing these crucial aspects of the virus/host interaction (Kuritzkes, D. R. and B. D. Walker (2007). HIV-1 Pathogenesis, Clinical Manifestations and Treatment. Fields Virology. D. Knipe and P. M. Howley. Philadelphia, PA, Lippincott Williams & Wilkins. 2: 2187-2214; Levy, J. A. (2007). HIV and the Pathogenesis of AIDS. Washington, D.C., ASM Press; Zwick, M. B. and D. R. Burton (2007). HIV-1 neutralization: mechanisms and relevance to vaccine design. Curr HIV Res 5(6): 608-24; Alter, G. and M. Altfeld (2009). NK cells in HIV-1 infection: evidence for their role in the control of HIV-1-infection. J Intern Med 265(1): 29-42; Neil, S. and P. Bieniasz (2009). Human immunodeficiency virus, restriction factors, and interferon. J Interferon Cytokine Res 29(9): 569-80; Stamatatos, L., L. Morris, et al. (2009). Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine? Nat Med 15(8): 866-70; Strebel, K., J. Luban, et al. (2009). Human cellular-restriction factors that target HIV-1 replication. BMC Med 7: 48; Altfeld, M., L. Fadda, et al. (2011). DCs and NK cells: critical effectors in the immune response to HIV-1. Nat Rev Immunol 11(3): 176-86).

AB - The defining features of the acquired immunodeficiency are the-persistent and profound selective decrease in the function as well as number of T lymphocytes of the helper/inducer subset and a possible activation of the suppressor/cytotoxic subset, as described in 1982 (Mildvan, D., U. Mathur, et al. (1982). Opportunistic infections and immune deficiency in homosexual men. Ann Intern Med 96(6 Pt 1): 700-4). Nowadays, although depletion of CD4+ T-cells remains a hallmark of Human Immunodeficiency Virus (HIV) infection, the multifactorial nature of the disease provoked by infection by HIV-1 or Simian Immunodeficiency Virus (SIV) in non-natural hosts is generally acknowledged, in that no unique immune alteration has been identified that can fully explain the plethora of dysregulation associated with the development of pathogenic HIV and SIV infection. This review will focus on what we know (or do not know) about T cell responses during HIV infection. This choice reflects the main expertise of the authors, and the major theme of this book. However, other aspects of adaptive and innate immunity should not be overlooked. Notably, HIV-specific antibodies, including neutralizing antibodies, are an important defense of the adaptive immune system, although HIV appears to quickly evade the effect of these antibodies. Recent studies have also highlighted the role of innate immunity in protection against HIV/SIV. In addition, several cellular antiretroviral restriction factors, either constitutively expressed or induced by interferons, have been identified, which provide considerable-resistance to retroviral infection. For more on these topics, we refer readers to recent reviews summarizing these crucial aspects of the virus/host interaction (Kuritzkes, D. R. and B. D. Walker (2007). HIV-1 Pathogenesis, Clinical Manifestations and Treatment. Fields Virology. D. Knipe and P. M. Howley. Philadelphia, PA, Lippincott Williams & Wilkins. 2: 2187-2214; Levy, J. A. (2007). HIV and the Pathogenesis of AIDS. Washington, D.C., ASM Press; Zwick, M. B. and D. R. Burton (2007). HIV-1 neutralization: mechanisms and relevance to vaccine design. Curr HIV Res 5(6): 608-24; Alter, G. and M. Altfeld (2009). NK cells in HIV-1 infection: evidence for their role in the control of HIV-1-infection. J Intern Med 265(1): 29-42; Neil, S. and P. Bieniasz (2009). Human immunodeficiency virus, restriction factors, and interferon. J Interferon Cytokine Res 29(9): 569-80; Stamatatos, L., L. Morris, et al. (2009). Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine? Nat Med 15(8): 866-70; Strebel, K., J. Luban, et al. (2009). Human cellular-restriction factors that target HIV-1 replication. BMC Med 7: 48; Altfeld, M., L. Fadda, et al. (2011). DCs and NK cells: critical effectors in the immune response to HIV-1. Nat Rev Immunol 11(3): 176-86).

UR - http://www.scopus.com/inward/record.url?scp=84949177033&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84949177033&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-0484-2_8

DO - 10.1007/978-1-4614-0484-2_8

M3 - Chapter

AN - SCOPUS:84949177033

SN - 1461404835

SN - 9781461404835

VL - 9781461404842

SP - 141

EP - 169

BT - Control of Innate and Adaptive Immune Responses during Infectious Diseases

PB - Springer New York

ER -